UNICA IRIS Institutional Research Information System

MERCURO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 362.258
NA - Nord America 24.505
AS - Asia 9.596
SA - Sud America 1.512
AF - Africa 1.177
Continente sconosciuto - Info sul continente non disponibili 1.040
OC - Oceania 78
Totale 400.166
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 356.843
US - Stati Uniti d'America 24.088
SG - Singapore 3.541
CN - Cina 3.137
UA - Ucraina 1.466
BR - Brasile 1.185
SE - Svezia 1.179
VN - Vietnam 843
ZA - Sudafrica 827
GB - Regno Unito 617
FI - Finlandia 604
DE - Germania 547
FR - Francia 466
IN - India 426
HK - Hong Kong 303
BD - Bangladesh 262
CA - Canada 232
KR - Corea 164
AR - Argentina 109
IQ - Iraq 90
TR - Turchia 89
KE - Kenya 81
PK - Pakistan 79
ID - Indonesia 78
NL - Olanda 73
PH - Filippine 72
MX - Messico 70
BE - Belgio 69
ES - Italia 68
JP - Giappone 67
RU - Federazione Russa 66
SA - Arabia Saudita 59
CO - Colombia 58
PL - Polonia 52
UZ - Uzbekistan 46
MY - Malesia 44
ZM - Zambia 44
AU - Australia 43
EC - Ecuador 41
AE - Emirati Arabi Uniti 39
AT - Austria 39
MA - Marocco 36
NP - Nepal 32
CL - Cile 29
IR - Iran 27
UG - Uganda 27
VE - Venezuela 24
JO - Giordania 22
PY - Paraguay 22
JM - Giamaica 21
TH - Thailandia 20
TN - Tunisia 20
EG - Egitto 19
IE - Irlanda 19
IL - Israele 19
PE - Perù 19
NG - Nigeria 18
TW - Taiwan 17
RO - Romania 16
GH - Ghana 15
GR - Grecia 15
KW - Kuwait 15
LK - Sri Lanka 15
LT - Lituania 15
NZ - Nuova Zelanda 14
CR - Costa Rica 13
PT - Portogallo 13
AZ - Azerbaigian 12
FJ - Figi 12
KH - Cambogia 12
KZ - Kazakistan 12
OM - Oman 12
BG - Bulgaria 11
BO - Bolivia 11
DZ - Algeria 11
TZ - Tanzania 11
CU - Cuba 10
MW - Malawi 10
SV - El Salvador 10
TT - Trinidad e Tobago 10
UY - Uruguay 10
ZW - Zimbabwe 10
NO - Norvegia 9
ET - Etiopia 8
SN - Senegal 8
AL - Albania 7
DO - Repubblica Dominicana 7
EU - Europa 7
GT - Guatemala 7
HR - Croazia 7
KG - Kirghizistan 7
MU - Mauritius 7
PR - Porto Rico 7
CH - Svizzera 6
HN - Honduras 6
LC - Santa Lucia 6
MT - Malta 6
PA - Panama 6
QA - Qatar 6
RS - Serbia 6
Totale 399.015
Salva come PNG Salva come JPEG
Città #
Cagliari 345.759
Uta 9.994
Fairfield 2.497
Ashburn 1.964
Woodbridge 1.747
Singapore 1.637
Houston 1.383
Chandler 1.287
Dallas 1.143
Ann Arbor 1.137
San Jose 1.128
Wilmington 1.026
Seattle 960
Boardman 950
Cambridge 892
Nyköping 793
Jacksonville 774
Beijing 614
Dearborn 456
Los Angeles 397
Council Bluffs 380
Helsinki 366
Santa Clara 306
Nanjing 293
Hong Kong 274
Lauterbourg 269
The Dalles 268
Boston 256
Ho Chi Minh City 247
New York 229
Hefei 227
Johannesburg 219
Shanghai 174
Buffalo 172
Hanoi 167
San Diego 154
Seoul 147
São Paulo 108
Guangzhou 105
Dong Ket 104
Shenyang 102
Milan 100
Atlanta 94
Nanchang 90
Redwood City 89
Toronto 89
London 82
Hebei 80
Chicago 78
Cape Town 76
Orem 74
Tianjin 74
Changsha 72
Pretoria 71
Jiaxing 70
Columbus 64
Munich 60
Brooklyn 58
Redondo Beach 55
Frankfurt am Main 52
Phoenix 50
Tokyo 50
Chennai 48
Norwalk 48
San Francisco 48
Mountain View 45
Da Nang 44
Denver 44
Jinan 44
Nairobi 44
Brussels 43
Lusaka 42
Tashkent 42
Amsterdam 41
Montreal 40
Nuremberg 40
Orange 38
Rio de Janeiro 38
Verona 38
Dhaka 37
Mumbai 36
Durban 35
Belo Horizonte 33
Washington 33
Rome 32
Auburn Hills 31
Baghdad 31
Pune 31
Warsaw 31
Wuhan 31
Stockholm 29
Zhengzhou 29
Haiphong 28
Sassari 25
Ningbo 24
Jakarta 23
Kuala Lumpur 23
Kunming 23
Manchester 23
Ankara 22
Totale 383.970
Salva come PNG Salva come JPEG
Nome #
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography 4.381
Metabolomic approach to profile functional and metabolic changes in heart failure 4.238
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.186
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension 3.947
Endodontic infection and endothelial dysfunction are associated with different mechanisms in men and women 3.887
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy 3.586
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.570
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease 3.544
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.479
Effects of an adapted physical training on functional status, body composition and quality of life in persons with spinal cord injury paraplegia: a pilot study 3.436
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.415
Effects of a mini-trampoline rebounding exercise program on functional parameters, body composition and quality of life in overweight women 3.376
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance 3.355
Cardiovascular effects, body composition, quality of life and pain after a Zumba® fitness program in Italian overweight women 3.160
Epicardial fat thickness, an emerging cardiometabolic risk factor, is increased in young adults born preterm 3.147
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state 3.134
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 3.124
Metaboreflex-mediated hemodynamic abnormalities in individuals with coronary artery disease without overt signs or symptoms of heart failure 3.082
A case of SAPHO syndrome with endodontic implications and treatment with biologic drugs 3.069
Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine 3.024
Metabolomics and heart failure: a new and promising scientific approach 2.999
Coronary Artery Disease 2.940
Nitrergic system and plasmatic methylarginines: Evidence of their role in the perinatal programming of cardiovascular diseases 2.933
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X 2.848
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.834
Pharmacological treatment of vagal hyperactivity, a rare but potentially fatal cause of sudden cardiac death 2.800
Sex-related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model 2.771
Effects of a nordic walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson's disease 2.769
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells 2.763
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 2.755
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.753
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases 2.717
Fully-textile polymer-based ECG electrodes: overcoming the limits of metal-based textiles 2.711
Metabolomics, a promising approach to translational research in cardiology 2.696
Zumba Fitness and Women’s Cardiovascular Health: A SYSTEMATIC REVIEW 2.572
Aquatic exercise improves motor impairments in people with Parkinson's disease, with similar or greater benefits than land-based exercise: a systematic review 2.569
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 2.554
Premature vascular deterioration in young patients affected by Wilson's disease: a pilot study 2.552
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 2.496
Impaired endothelial function in hereditary angioedema during the symptom-free period 2.434
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity 2.423
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study. 2.418
Effects of an adapted physical activity program on motor and non-motor functions and quality of life in patients with Parkinson's disease 2.370
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 2.330
The perioperative dental screening and management of patients undergoing cardiothoracic, vascular surgery and other cardiovascular invasive procedures: A systematic review 2.317
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.313
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.295
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 2.286
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.256
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 2.246
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 2.222
Impaired central arterial elasticity in young adults born with intrauterine growth restriction 2.215
null 2.211
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation 2.198
Perioperative dental screening and treatment in patients undergoing cardio-thoracic surgery and interventional cardiovascular procedures. A consensus report based on RAND/UCLA methodology. 2.193
null 2.190
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus 2.181
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 2.180
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.167
Reply to comment on: “Nordic Walking for the Management of People with Parkinson Disease: A Systematic Review” 2.135
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 2.121
IGENDA protocol: gender differences in awareness, knowledge and perception of cardiovascular risk: an Italian multicenter study 2.112
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.108
Antineoplastic drug-induced cardiotoxicity: A redox perspective 2.107
Supervised aquatic-based exercise for men with coronary artery disease: a meta-analysis of randomised controlled trials 2.099
Antihypertensive therapy in children: differences in medical approach between the United States and Europe 2.088
Abnormal atrial activation at surface electrocardiogram examination in born underweight young adults 2.087
Trastuzumab-based adjuvant chemotherapy for breast cancer: Early myocardial dysfunction detected by "speckle tracking" echocardiography (STE). 2.087
The need of a gender-corrected evidence based medicine 2.083
Clinical metabolomics and hematic ADMA predict the future onset of cardiorenal syndrome in young grown-up subjects who were born preterm 2.066
Could ADMA levels in young adults born preterm predict an early endothelial dysfunction? 2.027
Association of endodontic infection with detection of an initial lesion to the cardiovascular system 2.002
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens 1.991
Apical periodontitis and cardiovascular diseases: previous findings and ongoing research 1.981
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention 1.974
Altered aortic upper wall TDI velocity is inversely related with left ventricular diastolic function in operated tetralogy of Fallot 1.968
An old drug for use in the prevention of sudden infant unexpected death due to vagal hypertonia 1.956
Metabolic pathways in heart failure correlate with impaired longitudinal global strain rate 1.946
Ultrasound examination for the detection of simulated periapical bone lesions in bovine mandibles: an ex vivo study 1.940
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 1.935
Diabetic cardiomyopathy and ischemic heart disease: Prevention and therapy by exercise and conditioning 1.929
Current views on anthracycline cardiotoxicity 1.913
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 1.887
Arterial hypertension in the female world: Pathophysiology and therapy 1.880
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer 1.875
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography 1.836
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients 1.795
Multimodality imaging diagnosis of multiple ventricular thrombosis and massive stroke after gemcitabine and cisplatin chemotherapy for Urothelial Cancer 1.789
Gender differences in cardiology: is it time for new guidelines? 1.769
Preventing antiblastic drug-related cardiomyopathy: Old and new therapeutic strategies 1.768
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 1.735
Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib 1.722
A systematic overview to quantify the gender imbalance in cardiovascular rehabilitation trials 1.722
L’analisi metabolomica delle vie metaboliche nei pazienti affetti da scompenso cardiaco correla con lo strain rate longitudinale 1.706
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 1.687
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.675
Cardiovascular prevention in women: A narrative review from the Italian Society of Cardiology working groups on 'Cardiovascular Prevention, Hypertension and peripheral circulation' and on 'Women Disease' 1.665
Gender-specific aspects in primary and secondary prevention of cardiovascular disease 1.643
Impaired Forearm Blood Flow and Vasodilator Reserve in Healthy Postmenopausal Women 1.623
Atrial fibrillation in a preterm newborn with structurally normal heart 1.598
Totale 245.647
Salva come PNG Salva come JPEG
Categoria #
all - tutte 529.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 529.324
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216.351 0 1.204 956 1.607 1.395 1.332 989 1.155 1.895 1.689 1.954 2.175
2022/202326.476 2.651 3.900 3.513 2.267 2.246 2.258 1.128 2.121 1.730 1.465 2.036 1.161
2023/202430.921 1.668 1.166 1.376 2.261 3.046 4.843 4.853 2.585 1.702 2.132 2.768 2.521
2024/202555.265 10.433 13.562 9.788 6.654 3.121 4.922 3.911 375 708 521 587 683
2025/202617.604 956 784 2.130 1.444 1.292 1.424 2.973 1.643 1.300 1.799 930 929
2026/20271.345 568 777 0 0 0 0 0 0 0 0 0 0
Totale 400.166